FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Randolph Marks

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Sandeep M Patel; Kunal C Kadakia; Joseph J Maleszewski; Randolph S Marks
Straight to the heart: pulmonary vein leiomyosarcoma.
Mariza de Andrade; Claude Deschamps; Ruoxiang Jiang; Yan Li; Andrew H Limper; Randolph S Marks; David E Midthun; Curtis L Olswold; Paul D Scanlon; Zhifu Sun; Stephen J Swensen; Jason A Wampfler; Julie M Cunningham; Ping Yang
Genetic variants associated with the risk of chronic obstructive pulmonary disease with and without lung cancer.
Alfonso J Tafur; Henna Kalsi; Waldemar E Wysokinski; Robert D McBane; Aneel A Ashrani; Randolph S Marks; Daniel J Crusan; Tanya M Petterson; Kent R Bailey; John A Heit
The association of active cancer with venous thromboembolism location: a population-based study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Randolph Marks (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sandeep M Patel; Kunal C Kadakia; Joseph J Maleszewski; Randolph S Marks
Straight to the heart: pulmonary vein leiomyosarcoma.
The American journal of medicine 2013;126(2):117-9.
2012: Mariza de Andrade; Claude Deschamps; Ruoxiang Jiang; Yan Li; Andrew H Limper; Randolph S Marks; David E Midthun; Curtis L Olswold; Paul D Scanlon; Zhifu Sun; Stephen J Swensen; Jason A Wampfler; Julie M Cunningham; Ping Yang
Genetic variants associated with the risk of chronic obstructive pulmonary disease with and without lung cancer.
Cancer prevention research (Philadelphia, Pa.) 2012;5(3):365-73.
2011: Alfonso J Tafur; Henna Kalsi; Waldemar E Wysokinski; Robert D McBane; Aneel A Ashrani; Randolph S Marks; Daniel J Crusan; Tanya M Petterson; Kent R Bailey; John A Heit
The association of active cancer with venous thromboembolism location: a population-based study.
Mayo Clinic proceedings. Mayo Clinic 2011;86(1):25-30.
2010: Zhifu Sun; Junjie Chen; J Aakre; Randolph S Marks; Y Y Garces; R Jiang; O Idowu; Julie M Cunningham; Y Liu; V Shane Pankratz; Ping Yang
Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small-cell lung cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(10):2011-6.
2010: Joseph Y Chang; Randolph S Marks; David M Nagorney; Schuyler O Sanderson; Sunanda Kane
Ulcerative colitis, infliximab, and hepatic epithelioid hemangioendothelioma: who is to blame? Case Report.
Therapeutic advances in gastroenterology 2010;3(3):203-6.
2010: Yafei Li; Chau-Chyun Sheu; Yuanqing Ye; Mariza de Andrade; Liang Wang; Shen-Chih Chang; Marie C Aubry; Jeremiah A Aakre; Mark S Allen; Feng Chen; Julie M Cunningham; Claude Deschamps; Ruoxiang Jiang; Jie Lin; Randolph S Marks; V Shane Pankratz; Li Su; Yan Li; Zhifu Sun; Hui Tang; George Vasmatzis; Curtis C Harris; Margaret R Spitz; Jin Jen; Renyi Wang; Zuo-Feng Zhang; David C Christiani; Xifeng Wu; Ping Yang
Genetic variants and risk of lung cancer in never smokers: a genome-wide association study.
The lancet oncology 2010;11(4):321-30.
2010: Sumithra J Mandrekar; Yingwei Qi; Shauna L Hillman; Katie L Allen Ziegler; Nicholas F Reuter; Kendrith M Rowland; Steven A Kuross; Randolph S Marks; Steven E Schild; Alex A. Adjei
Endpoints in phase II trials for advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(1):3-9.
2009: Nathan R Foster; Sumithra J Mandrekar; Steven E Schild; Garth D Nelson; Kendrith M Rowland; Richard L Deming; Timothy F Kozelsky; Randolph S Marks; James R Jett; Alex A. Adjei
Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.
Cancer 2009;115(12):2721-31.
2008: Farrah Mateen; Aminah Jatoi; Timothy W Lineberry; Dawn Aranguren; Edward T. Creagan; Gary A Croghan; James R Jett; Randolph S Marks; Julian R Molina; Ronald L Richardson
Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report.
Psycho-oncology 2008;17(7):721-5.
2008: Ping Yang; Zhifu Sun; Michael J Krowka; Marie-Christine Aubry; William R Bamlet; Jason A Wampfler; Stephen N Thibodeau; Jerry A Katzmann; Mark S Allen; David E Midthun; Randolph S Marks; Mariza de Andrade
Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk.
Archives of internal medicine 2008;168(10):1097-103.
2008: Elizabeth A Johnson; Randolph S Marks; Sumithra J Mandrekar; Shauna Hillman; Mark D Hauge; Mitchel D Bauman; Edward J Wos; Dennis F Moore; John W Kugler; Harold E Windschitl; David Graham; Albert M Bernath; Tom R Fitch; Gamini S Soori; James R Jett; Alex A. Adjei; Edith A Perez
Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51).
Lung cancer (Amsterdam, Netherlands) 2008;60(2):200-7.
2007: Jann N. Sarkaria; Paul Schwingler; Steven E Schild; Patrick T Grogan; Ann C Mladek; Sumithra J Mandrekar; Angelina D Tan; Takao Kobayashi; Randolph S Marks; Hirohito Kita; Robert C Miller; Andrew H Limper; Edward B Leof
Phase I trial of sirolimus combined with radiation and cisplatin in non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(8):751-7.
2007: Steven E Schild; James A. Bonner; Shauna Hillman; Timothy F Kozelsky; Antonio P G Vigliotti; Randolph S Marks; David Graham; Gamini S Soori; John W Kugler; Richard C Tenglin; Donald B Wender; Alex A. Adjei
Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(21):3124-9.
2007: Harrup Kaur; Helmut Buettner; Diva R Salomao; Randolph S Marks
Transcleral orbital invasion by a radiation and chemotherapy-resistant choroidal metastasis of a pulmonary adenocarcinoma.
American journal of ophthalmology 2007;143(2):369-70.
2006: Jan C Buckner; Karla V Ballman; John C Michalak; Gary V Burton; Terrence L Cascino; Paula J Schomberg; Roland B Hawkins; Bernd W Scheithauer; Howard M Sandler; Randolph S Marks; Judith R O'Fallon
Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3871-9.
2006: Sumithra J Mandrekar; Steven E Schild; Shauna Hillman; Katie L Allen; Randolph S Marks; James A Mailliard; James E Krook; Andrew W Maksymiuk; Kari Chansky; Karen Kelly; Alex A. Adjei; James R Jett
A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials.
Cancer 2006;107(4):781-92.
2006: Sumithra J Mandrekar; Donald W Northfelt; Steven E Schild; Nathan R Foster; Brian Bot; Randolph S Marks; James A Mailliard; James E Krook; Andrew W Maksymiuk; Alex A. Adjei; James R Jett
Impact of pretreatment factors on adverse events: a pooled analysis of North Central Cancer Treatment Group advanced stage non-small cell lung cancer trials.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(6):556-63.
2006: Zhifu Sun; Marie-Christine Aubry; Claude Deschamps; Randolph S Marks; Scott H Okuno; Brent A Williams; Hiroshi Sugimura; V Shane Pankratz; Ping Yang
Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases.
The Journal of thoracic and cardiovascular surgery 2006;131(5):1014-20.
2005: Ping Yang; Mark S Allen; Marie-Christine Aubry; Jason A Wampfler; Randolph S Marks; Eric S Edell; Stephen Thibodeau; Alex A. Adjei; James Jett; Claude Deschamps
Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003.
Chest 2005;128(1):452-62.
2005: Ping Yang; William R Bamlet; Zhifu Sun; Jon O Ebbert; Marie-Christine Aubry; Michael J Krowka; William R Taylor; Randolph S Marks; Claude Deschamps; Stephen J Swensen; Eric D Wieben; Julie M Cunningham; Joseph L Melton; Mariza de Andrade
Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk.
Chest 2005;128(1):445-52.
2004: Steven E Schild; James A. Bonner; Thomas G Shanahan; Burke J Brooks; Randolph S Marks; Susan M Geyer; Shauna Hillman; Gist Henry Farr; Henry D Tazelaar; James E Krook; Francois J Geoffroy; Muhammad Salim; Robert M Arusell; James A Mailliard; Paul L Schaefer; James R Jett
Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer.
International journal of radiation oncology, biology, physics 2004;59(4):943-51.
2004: Antonio L Visbal; Brent A Williams; Francis C Nichols; Randolph S Marks; James R Jett; Marie-Christine Aubry; Eric S Edell; Jason A Wampfler; Julian R Molina; Ping Yang
Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002.
The Annals of thoracic surgery 2004;78(1):209-15; discussion 215.
2004: Edith A Perez; Francois J Geoffroy; Shauna Hillman; Elizabeth A Johnson; Gist Henry Farr; Henry D Tazelarr; Alan K Hatfield; James E Krook; James A Maillard; Ralph Levitt; Randolph S Marks
Phase II study of oral etoposide and intravenous paclitaxel in extensive-stage small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2004;44(3):347-53.
2004: M de Andrade; J O Ebbert; Jason A Wampfler; Daniel L Miller; Randolph S Marks; Gary A Croghan; Aminah Jatoi; E E Finke; T A Sellers; Ping Yang
Environmental tobacco smoke exposure in women with lung cancer.
Lung cancer (Amsterdam, Netherlands) 2004;43(2):127-34.
2004: Steven Vernino; Brian Patrick O'Neill; Randolph S Marks; Judith R O'Fallon; David W Kimmel
Immunomodulatory treatment trial for paraneoplastic neurological disorders.
Neuro-oncology 2004;6(1):55-62.
2003: Randolph S Marks; David Graham; Jeff A Sloan; Shauna Hillman; Steven Fishkoff; James E Krook; Scott H Okuno; James A Mailliard; Tom R Fitch; Ferdinand K Addo
A phase II study of the dolastatin 15 analogue LU 103793 in the treatment of advanced non-small-cell lung cancer.
American journal of clinical oncology 2003;26(4):336-7.
2003: Alex A. Adjei; Gary A Croghan; Charles Erlichman; Randolph S Marks; Joel M Reid; Jeff A Sloan; Henry C Pitot; Steven R Alberts; Richard M Goldberg; Lorelei J Hanson; Laura M Bruzek; Pamela J Atherton; Alain Thibault; Peter A Palmer; Scott H Kaufmann
A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2520-6.
2003: Paul L Schaefer; Randolph S Marks; Michelle R Mahoney; Jeff A Sloan; Mitchell D Bauman; Henry D Tazelaar; John W Kugler; James A Mailliard; Larry P Ebbert; Martin Wiesenfeld
Randomized phase II study of daily versus continuous-infusion schedules of topotecan in the treatment of extensive-stage small cell lung cancers.
American journal of clinical oncology 2003;26(3):236-40.
2003: James R Jett; Alan K Hatfield; Shauna Hillman; Michael D Bauman; James A Mailliard; John W Kugler; Roscoe F Morton; Randolph S Marks; Ralph Levitt
Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group.
Cancer 2003;97(10):2498-503.
2003: Alex A. Adjei; Ann Mauer; Laura M Bruzek; Randolph S Marks; Shauna Hillman; Susan Geyer; Lorelei J Hanson; John J Wright; Charles Erlichman; Scott H Kaufmann; Everett E Vokes
Phase II study of the farnesyl transferase inhibitor R115777 in patients with advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(9):1760-6.
2002: Lisa Sanderson Cox; Jeff A Sloan; Christi A Patten; James A. Bonner; Susan M Geyer; William L McGinnis; Philip J Stella; Randolph S Marks
Smoking behavior of 226 patients with diagnosis of stage IIIA/IIIB non-small cell lung cancer.
Psycho-oncology 2002;11(6):472-8.
2002: Steven E Schild; Philip J Stella; Susan M Geyer; James A. Bonner; Randolph S Marks; William L McGinnis; Steven P Goetz; Steven A Kuross; James A Mailliard; John W Kugler; Paul L Schaefer; James R Jett
Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer.
International journal of radiation oncology, biology, physics 2002;54(2):370-8.
2002: Ping Yang; Akira Yokomizo; Henry D Tazelaar; Randolph S Marks; Timothy G Lesnick; Daniel L Miller; Jeff A Sloan; Eric S Edell; Rebecca L Meyer; James Jett; Wanguo Liu
Genetic determinants of lung cancer short-term survival: the role of glutathione-related genes.
Lung cancer (Amsterdam, Netherlands) 2002;35(3):221-9.
2002: Stephen J Swensen; James R Jett; Jeff A Sloan; David E Midthun; Thomas E Hartman; Anne-Marie Sykes; Gregory L Aughenbaugh; Frank E Zink; Shauna Hillman; Gayle R Noetzel; Randolph S Marks; Amy C Clayton; Peter C Pairolero
Screening for lung cancer with low-dose spiral computed tomography.
American journal of respiratory and critical care medicine 2002;165(4):508-13.
2002: Jeff A Sloan; James A. Bonner; Shauna Hillman; Cristine Allmer; Thomas G Shanahan; Burke J Brooks; Randolph S Marks; Delfino Vargas-Chanes; James R Jett
A quality-adjusted reanalysis of a Phase III trial comparing once-daily thoracic radiation vs. twice-daily thoracic radiation in patients with limited-stage small-cell lung cancer(1).
International journal of radiation oncology, biology, physics 2002;52(2):371-81.
2002: John H Edmonson; Randolph S Marks; Jan C Buckner; Michelle R Mahoney
Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas.
Cancer investigation 2002;20(5-6):605-12.
2001: Paul D. Brown; James A. Bonner; Robert L Foote; Stephen Frytak; Randolph S Marks; Ronald L Richardson; Edward T. Creagan
Long-term results of a phase I/II study of high-dose thoracic radiotherapy with concomitant cisplatin and etoposide in limited stage small-cell lung cancer.
American journal of clinical oncology 2001;24(6):556-61.
2001: Gerardo Colon-Otero; R D Niedringhaus; S H Hillman; Susan Geyer; J Sloan; James E Krook; Harold E Windschitl; Randolph S Marks; Martin Wiesenfeld; Loren K Tschetter; J J Jett
A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Central Cancer Treatment Group Trial.
American journal of clinical oncology 2001;24(6):551-5.
2000: Alex A. Adjei; Charles Erlichman; JN Davis; David L Cutler; Jeff A Sloan; Randolph S Marks; Lorelei J Hanson; Phyllis A Svingen; Pamela J Atherton; W Robert Bishop; Paul Kirschmeier; Scott H Kaufmann
A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity.
Cancer research 2000;60(7):1871-7.
2000: J A Bonner; Jeff A Sloan; Jr. Kendrith M. Rowland; G G Klee; John W Kugler; James A Mailliard; Martin Wiesenfeld; J E Krook; Andrew W Maksymiuk; Edward G Shaw; Randolph S Marks; Edith A Perez
Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(2):597-601.
1999: RJ Kirschling; JP Grill; Randolph S Marks; John W Kugler; JB Gerstner; Steven A Kuross; John C Michalak; Harold E Windschitl; K D Krewer; James R Jett
Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment Group.
American journal of clinical oncology 1999;22(5):517-22.
1999: James A. Bonner; Jeff A Sloan; Thomas G Shanahan; Burke J Brooks; Randolph S Marks; James E Krook; JB Gerstner; Andrew W Maksymiuk; Ralph Levitt; James A Mailliard; Henry D Tazelaar; Shauna Hillman; James R Jett
Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2681-91.
1999: Alex A. Adjei; Randolph S Marks; James A. Bonner
Current guidelines for the management of small cell lung cancer.
Mayo Clinic proceedings. Mayo Clinic 1999;74(8):809-16.
1999: Ping Yang; K A Wentzlaff; Jerry A Katzmann; Randolph S Marks; Mark S Allen; Timothy G Lesnick; Noralane M Lindor; Jeffrey L Myers; Elaine Wiegert; David E Midthun; Stephen N Thibodeau; Michael J Krowka
Alpha1-antitrypsin deficiency allele carriers among lung cancer patients.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1999;8(5):461-5.
1999: SV Rajkumar; Patrick A Burch; Suresh Nair; Robert P Dinapoli; Bernd W Scheithauer; Judith R O'Fallon; P S Etzell; J M Leitch; Roscoe F Morton; Randolph S Marks
Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent glioma.
American journal of clinical oncology 1999;22(2):168-71.
1998: SV Rajkumar; Jan C Buckner; Paula J Schomberg; Joel M Reid; P J Bagniewski; Matthew M Ames; Terrence L Cascino; Randolph S Marks
Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.
International journal of radiation oncology, biology, physics 1998;42(5):969-75.
1998: Andrew W Maksymiuk; RF Marschke; Henry D Tazelaar; J Grill; Suresh Nair; Randolph S Marks; Burke J Brooks; James A Mailliard; G M Burton; James R Jett
Phase II trial of topotecan for the treatment of mesothelioma.
American journal of clinical oncology 1998;21(6):610-3.
1997: TE Sawyer; James A. Bonner; PM Gould; Robert L Foote; Claude Deschamps; Victor F Trastek; Peter C Pairolero; M S Allen; Edward G Shaw; Randolph S Marks; Stephen Frytak; CM Lange; H Li
The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement.
Cancer 1997;80(8):1399-408.
1997: Edward T. Creagan; Kendrith M Rowland; Vera J Suman; Carl G Kardinal; RF Marschke; Randolph S Marks; William J Maples
Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced malignant melanoma.
American journal of clinical oncology 1997;20(5):490-2.
1995: J R Jett; R J Kirschling; S H Jung; Randolph S Marks
A phase II study of paclitaxel and granulocyte colony-stimulating factor in previously untreated patients with extensive-stage small cell lung cancer: a study of the North Central Cancer Treatment Group.
Seminars in oncology 1995;22(3 Suppl 6):75-7.